Heron Therapeutics | Zysk Brutto Na Sprzedaży





Zysk Brutto Na Sprzedaży Zmiana Data
ALKERMES USD 265.83M 8.06M 2025-09
Alnylam Pharmaceuticals USD 1.05B 418.14M 2025-09
Amarin USD 22.21M 28.15M 2025-09
ANI Pharmaceuticals USD 111.79M 1.68M 2025-09
Anika Therapeutics USD 14.68M 9.46M 2025-03
Arrowhead Research USD 256.47M 228.7M 2025-09
Eisai JPY 168.85B 17.02B 2025-12
Esperion Therapeutics USD -29.52M 32.4M 2024-09
GlaxoSmithKline GBP 6.18B 106M 2025-12
Heron Therapeutics USD 23.35M 1.6M 2024-09
Insmed USD 111.44M 33.36M 2025-09
Ligand Pharmaceuticals USD 155.28M 82.42M 2025-09
Merck USD 13.42B 431M 2025-09
Nektar Therapeutics USD 13.75M 650K 2024-06
Neurocrine Biosciences USD 780.9M 104.7M 2025-09
Omeros USD -33.16M 18.52M 2024-06
Pacira USD 130.92M 5M 2025-09
Regeneron Pharmaceuticals USD 3.3B 67M 2025-12
Roche Holding CHF 22.09B 10.04B 2025-12
Sangamo BioSciences -2.39M 1.09M 2024-06
Surmodics USD -11.54M 3.99M 2024-09
Ultragenyx Pharmaceutical USD 131.94M 11.55M 2025-09
Veracyte USD 91.28M 1.51M 2025-09
Vertex Pharmaceuticals USD 2.66B 104.4M 2025-09


Heron Therapeutics Zysk Brutto Na Sprzedaży - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.